Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Gellai
SB 209670, a Rationally Designed Potent Nonpeptide Endothelin Receptor Antagonist.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
Rationally Designed Polycationic Carriers for Potent Polymeric siRNA-Mediated Gene Silencing
ACS Nano
Materials Science
Nanoscience
Engineering
Nanotechnology
Astronomy
Physics
Potent Anti-Inflammatory and Antinociceptive Activity of the Endothelin Receptor Antagonist Bosentan in Monoarthritic Mice
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
Rationally Designed Tularemia Vaccines
Expert Review of Vaccines
Molecular Medicine
Drug Discovery
Immunology
Pharmacology
Delaminomycins, Novel Nonpeptide Extracellular Matrix Receptor Antagonist and a New Class of Potent Immunomodulator. I. Taxonomy, Fermentation, Isolation and Biological Activity.
Journal of Antibiotics
Drug Discovery
Pharmacology
Metabolism-Based Identification of a Potent Thrombin Receptor Antagonist
Effects of WIN 64338, a Nonpeptide Bradykinin B2 Receptor Antagonist, on Guinea-Pig Trachea
British Journal of Pharmacology
Pharmacology
The Effects of an Endothelin-A Receptor Antagonist on Choroidal Circulation
Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
A Novel Nonpeptide CGRP Receptor Antagonist, ‘Compound 1’ (WO98/11128) Is a High Affinity Competitive Antagonist at the CGRP1 Receptor in Human Coronary Arteries
The Scientific World Journal
Biochemistry
Medicine
Genetics
Molecular Biology
Environmental Science
Rationally Designed Complex, Hierarchical Microarchitectures
Science
Multidisciplinary
Philosophy of Science
History